EMAIL THIS PAGE TO A FRIEND

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Protective role of the dynamin inhibitor Dynasore against the cholesterol-dependent cytolysin of Trueperella pyogenes.


PMID 25550455

Abstract

The virulence of many Gram-positive bacteria depends on cholesterol-dependent cytolysins (CDCs), which form pores in eukaryotic cell plasma membranes. Pyolysin (PLO) from Trueperella pyogenes provided a unique opportunity to explore cellular responses to CDCs because it does not require thiol activation. Sublytic concentrations of PLO stimulated phosphorylation of MAPK ERK and p38 in primary stromal cells, and induced autophagy as determined by protein light-chain 3B cleavage. Although, inhibitors of MAPK or autophagy did not affect PLO-induced cytolysis. However, 10 μM 3-hydroxynaphthalene-2-carboxylic acid-(3,4-dihydroxybenzylidene)-hydrazide (Dynasore), a dynamin guanosine 5'-triphosphatase inhibitor, protected stromal cells against PLO-induced cytolysis as determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay (85 ± 17% versus 50 ± 9% cell viability), measuring extracellular ATP, and kinetic assays. This was a generalized mechanism because Dynasore also protected HeLa cells against streptolysin O. Furthermore, the effect was reversible, with stromal cell sensitivity to PLO restored within 30 minutes of Dynasore removal. The protective effect of Dynasore was not conferred by dynamin inhibition, induction of ERK phosphorylation, or Dynasore binding to PLO. Rather, Dynasore reduced cellular cholesterol and disrupted plasma membrane lipid rafts, similar to positive control methyl-β-cyclodextrin. Dynasore is a tractable tool to explore the complexity of cholesterol homeostasis in eukaryotic cells and to develop strategies to counter CDCs.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4200361
Anti-LC3B antibody, Mouse monoclonal, clone LC3B-6, purified from hybridoma cell culture
SAB2700738
Anti-Map1lc3b antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB3501065
Anti-MAP1LC3B antibody produced in rabbit, affinity isolated antibody
SAB4300497
Anti-MAPK9 (Ab-183) antibody produced in rabbit, affinity isolated antibody
GW22791 Anti-MAPK9 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB2502040
Anti-MAPK9 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2502041
Anti-MAPK9 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1412229
ANTI-MAPK9 antibody produced in mouse, clone 3C12, purified immunoglobulin, buffered aqueous solution
SAB4502402
Anti-MAPK9 antibody produced in rabbit, affinity isolated antibody
SAB2107297
Anti-MAPK9 antibody produced in rabbit, affinity isolated antibody
SAB4300198
Anti-phospho-MAPK9 (pThr183) antibody produced in rabbit, affinity isolated antibody
SAB4502399
Anti-SAPK antibody produced in rabbit, affinity isolated antibody
SAB4502400
Anti-SAPK antibody produced in rabbit, affinity isolated antibody
M8159
Monoclonal Anti-MAP Kinase, Activated (Diphosphorylated ERK-1&2) antibody produced in mouse, clone MAPK-YT, ascites fluid
WH0081631M1
Monoclonal Anti-MAP1LC3B antibody produced in mouse, clone 4E11, purified immunoglobulin, buffered aqueous solution
SAB1405293
Monoclonal Anti-MAP1LC3B antibody produced in mouse, clone 4G7, purified immunoglobulin, buffered aqueous solution
SAB1404250
Monoclonal Anti-MAPK9, (C-terminal) antibody produced in mouse, clone 2F8, purified immunoglobulin, buffered aqueous solution